Clinical Evaluation of Toric Intraocular Lens

Inclusion Criteria: * Patients with age of 40 years or older * Patients with age-related cataract in one eye or both eyes. * Patients willing to participate in the required postoperative study. * Patient who can understand and sign the consent document. * An eye whose pupil diameter after mydriasis is 5 mm or greater. * An eye whose preoperative corneal cylindrical power is 1.0D or more. * An eye whose postoperative astigmatism is predicted to be less than 0.5 D. * An eye whose postoperative visual acuity with spherical addition is 0.8 D or more. Exclusion Criteria: * Disorder of corneal endothelium * Uncontrolled glaucoma * Active Uveitis * Diabetic retinopathy * Retinal detachment * Congenital ocular anomalies * Choroidal hemorrhage * Shallow anterior chamber * Microphthalmus * Corneal dystrophy * Optic atrophy * Ocular hypertension * Amblyopia * Previous history of corneal transplantation * Active Iritis * Corneal disorder * Macular degeneration * Retinal degeneration * Clinically significant change in macula and/or retinal pigment epithelium * Corneal irregular astigmatism * Atopic disease * Brittleness of Zinn's zonule, fractured zonule and lens luxation (including subluxation) * Pseudo-exfoliation syndrome * Iris neovascularization * Long axis length eye (axis length : 28mm or more) * Severe dry eye, abnormality of the lens surface * Concurrent participation in another drug and device clinical investigation * Patient with mental deficiency or psychiatric disorder and/or who is not capable of expressing the consent of participating in the trial * Patient who is judged inappropriate by investigators or sub-investigators